FDA Approved: OXALIPLATIN — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

The FDA approved a generic oxaliplatin product from Sagent Pharmaceuticals under an Original Abbreviated New Drug Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

ORIG AP for OXALIPLATIN (OXALIPLATIN)